| Discharge Regimen (w/ or w/o Steroids Use) | All | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CyA | Tac | CyA+ MMF | Tac+ MMF | CyA+ Aza | Tac+ Aza | Siro+ MMF | CyA+ Siro | Tac+ Siro | Other | ||
| Functioning Graft with Immunosuppression Info at Discharge | 1 | 151 | 72 | 3,326 | 1 | 12 | 53 | 149 | 218 | 284 | 4,267 |
| % of All Regimens | 0.0% | 3.5% | 1.7% | 77.9% | 0.0% | 0.3% | 1.2% | 3.5% | 5.1% | 6.7% | 100.0% |
| Induction Drug | 0.0% | 2.6% | 1.4% | 2.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.5% | 1.8% | 1.8% |
| Atgam/NRATG/NRATS | |||||||||||
| OKT3 | 0.0% | 1.3% | 0.0% | 0.7% | 0.0% | 0.0% | 1.9% | 0.0% | 1.8% | 2.8% | 0.9% |
| Thymoglobulin | 100.0% | 30.5% | 66.7% | 52.6% | 0.0% | 75.0% | 20.8% | 89.3% | 43.1% | 84.2% | 54.6% |
| Zenapax | 0.0% | 6.6% | 1.4% | 6.2% | 0.0% | 0.0% | 1.9% | 0.0% | 2.8% | 3.2% | 5.5% |
| Simulect | 0.0% | 2.6% | 15.3% | 9.2% | 0.0% | 16.7% | 0.0% | 0.7% | 1.8% | 5.3% | 8.0% |
| Campath | 0.0% | 29.1% | 1.4% | 11.3% | 0.0% | 0.0% | 69.8% | 0.7% | 28.0% | 22.9% | 13.7% |
| No Induction Drugs Recorded | 0.0% | 30.5% | 16.7% | 20.6% | 100.0% | 8.3% | 9.4% | 10.1% | 26.1% | 9.9% | 19.9% |